Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use
US5597707A · kind A · utility
17Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 1993 |
| Grant date | Jan 28, 1997 |
| Priority date | — |
| Expiry date | Apr 15, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention definitively identifies and characterizes the tumor-associated antigen immunologically recognized by the murine monoclonal antibody L6. Further, the present invention provides the nucleotide sequence which encodes the L6 antigen. Various diagnostic, prophylactic and therapeutic methods comprising the L6 antigen and the nucleotide sequence which encodes the L6 antigen are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.